Document Detail


Fusion of bone marrow-derived stem cells with striated muscle may not be sufficient to activate muscle genes.
MedLine Citation:
PMID:  15578085     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Several studies have demonstrated the existence of pluripotent bone marrow-derived stem cells capable of homing to injured cardiac and skeletal muscle; however, there has been little evidence demonstrating the induction of tissue-specific endogenous genes in donor stem cells following engraftment. A new study in this issue reports an intriguing finding that raises additional concerns relating to stem cell plasticity and stem cell therapy in an already heated and controversial field. The study demonstrates that wild-type bone marrow-derived side population stem cells are indeed readily incorporated into both skeletal and cardiac muscle when transplanted into mice that lack delta-sarcoglycan -- a model of cardiomyopathy and muscular dystrophy. However, these cells fail to express sarcoglycan and thus to repair the tissue, which suggests that this stem cell population has limited potential for cardiac and skeletal muscle regeneration.
Authors:
Giulio Cossu
Related Documents :
23881915 - Altered natural killer cell subset homeostasis and defective chemotactic responses in p...
23190805 - Subcutaneous fat tissue engineering using autologous adipose-derived stem cells seeded ...
24088735 - Activity of the hypoxia-activated prodrug, th-302, in preclinical human acute myeloid l...
25080485 - Programmed death-1 pathway in host tissues ameliorates th17/th1-mediated experimental c...
10817635 - Acute trypanosoma cruzi infection is associated with anemia, thrombocytopenia, leukopen...
305905 - The effect of x-rays and neutrons on lymphocyte death and transformation.
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  114     ISSN:  0021-9738     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2004-12-03     Completed Date:  2005-02-08     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1540-3     Citation Subset:  AIM; IM    
Affiliation:
Stem Cell Research Institute, DIBIT, Milan, Italy. cossu.giulio@hsr.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Fusion
Gene Expression Regulation*
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells / cytology,  physiology*
Mice
Muscle, Skeletal / cytology,  physiology*
Myocardium / cytology,  metabolism
Pluripotent Stem Cells / physiology*
Regeneration / physiology
Sarcoglycans / genetics,  metabolism
Chemical
Reg. No./Substance:
0/Sarcoglycans
Comments/Corrections
Comment On:
J Clin Invest. 2004 Dec;114(11):1577-85   [PMID:  15578090 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  PPARs in atherosclerosis: the clot thickens.
Next Document:  Marfan syndrome and mitral valve prolapse.